Triethylamine → 2-(6,7-Difluoro-1H-benzimidazol-1-yl)-N-[3-(trifluoromethyl)phenyl]acetamide

To a suspension of 4,5-difluoro-1H-benzimidazole (20 mg, 0.13 mmol) in toluene (260 μL), triethylamine (18 μL, 0.13 mmol) and 2-bromo-N-[3-(trifluoromethyl)phenyl]acetamide (37 mg, 0.13 mmol) were added. The reaction mixture was microwave-irradiated in a sealed vial at 120° C. for 30 min. The vial was cooled, opened and the contents dissolved in 20 mL ethyl acetate. The solution was washed with water (5 mL), saturated aqueous NaHCO3 (5 mL) and brine (5 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. Separation of the isomers in the crude product was performed on flash silica column using neat ethyl acetate to yield the title compound (11.3 mg, 25%). MS (ESI) m/z: 355.8 [M+H] 1H NMR (400 MHz, MeOD) δ ppm 5.31 (s, 2H), 7.20 (ddd, J=11.4, 9.0, 7.5 Hz, 1H), 7.40 (d, J=7.8 Hz, 1H), 7.47 (ddd, J=8.9, 3.7, 1.3 Hz, 1H), 7.52 (t, J=8.1 Hz, 1H), 7.79 (d, J=8.8 Hz, 1H), 7.96 (s, 1H), 8.20 (s, 1H).

1. additionwere added
2. customThe reaction mixture was microwave-irradiated in a sealed vial at 120° C. for 30 min
3. temperatureThe vial was cooled
4. washThe solution was washed with water (5 mL), saturated aqueous NaHCO3 (5 mL) and brine (5 mL)
5. dry with materialdried over anhydrous Na2SO4
6. concentrationconcentrated under reduced pressure
7. customSeparation of the isomers in the crude product

ORD-Eintrag

ord-09f8c0b82a214a57862cb7729af5df37

Quelldatensatz

uspto-grants-2010_01

DOI

10.6084/m9.figshare.5104873.v1

Patentnummer

US07645784B2